Literature DB >> 7226695

Thrombocytopenia in neonatal infection.

H D Modanlou, O B Ortiz.   

Abstract

Serial platelet counts by phase microscopy were done for three groups of neonates who were admitted to the Special Care Unit of the Miller Children's Hospital, Group 1 (78 neonates) was evaluated for septicemia. Group 2 (28 neonates) was randomly selected sick neonates whose working diagnosis was not septicemia. Group 3 (16 neonates) was clinically normal preterm neonates (28 to 36 weeks gestation). For group 1 and 2, platelet counts were done serially, at the time blood and cerebrospinal fluid cultures were obtained and then 12, 24, 48 and 72 hours later. For group 3, plasma counts were done on the second, seventh, fourteenth, twenty-first, and twenty-eighth day of life. Sixteen of the group 1 infants were found to have septicemia; ten of these 16 had thrombocytopenia (platelets less than 100,000/mm3). In group 2, five infants had thrombocytopenia, one because of isoimmune disease and four as a result of possible disseminated intravascular coagulation. Thrombocytopenia persisted for 1 to 10 days; platelet counts of group 3 were the same as those of older children and adults.

Entities:  

Mesh:

Year:  1981        PMID: 7226695     DOI: 10.1177/000992288102000605

Source DB:  PubMed          Journal:  Clin Pediatr (Phila)        ISSN: 0009-9228            Impact factor:   1.168


  3 in total

1.  Thrombocytopenia and bacterial sepsis in neonates.

Authors:  S H Arif; I Ahmad; S M Ali; H M Khan
Journal:  Indian J Hematol Blood Transfus       Date:  2011-10-05       Impact factor: 0.900

2.  Hemostatic profile in neonatal septicemia.

Authors:  V Alamelu; A K Dutta; S Narayan; A Saili
Journal:  Indian J Pediatr       Date:  1992 Mar-Apr       Impact factor: 1.967

3.  The cut-off levels of procalcitonin and C-reactive protein and the kinetics of mean platelet volume in preterm neonates with sepsis.

Authors:  C Aydemir; H Aydemir; F Kokturk; C Kulah; A G Mungan
Journal:  BMC Pediatr       Date:  2018-08-01       Impact factor: 2.125

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.